Zhao Chen

Innovative and experienced scientific leader with 14+ years of experience in translational oncology and immuno oncology drug discovery. Key areas of expertise include new target identification, validation, and candidate development. Deep knowledge of various in vivo pharmacology tumor modeling systems in support of pre-clinical and early clinical development across Oncology and Immuno-oncology. Pioneering the application of organoids, organ on chip and iPSC platforms in discovery pharmacology through tumor microenvironment recapitulation. Experienced mentor of principle scientists, senior scientists and junior associates.